Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells.

Yamazaki T, Ohmi A, Kurumaya H, Kato K, Abe T, Yamamoto H, Nakanishi N, Okuyama R, Umemura M, Kaise T, Watanabe R, Okawa Y, Takahashi S, Takahashi Y.

Life Sci. 2010 Aug 28;87(9-10):294-301. doi: 10.1016/j.lfs.2010.07.006. Epub 2010 Jul 21.

PMID:
20654631
2.

A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.

Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR.

Nat Med. 2010 Jun;16(6):671-7. doi: 10.1038/nm.2158. Epub 2010 May 23.

3.

The BCL-2 family reunion.

Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR.

Mol Cell. 2010 Feb 12;37(3):299-310. doi: 10.1016/j.molcel.2010.01.025. Review.

4.

Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells.

Li G, Li W, Angelastro JM, Greene LA, Liu DX.

Mol Cancer Res. 2009 Jun;7(6):933-43. doi: 10.1158/1541-7786.MCR-08-0365. Epub 2009 Jun 16.

5.

Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.

Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.

Cancer Res. 2008 Aug 15;68(16):6743-51. doi: 10.1158/0008-5472.CAN-07-6469.

6.

ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.

Pascual M, Gómez-Lechón MJ, Castell JV, Jover R.

Drug Metab Dispos. 2008 Jun;36(6):1063-72. doi: 10.1124/dmd.107.019380. Epub 2008 Mar 10.

7.

Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis.

Garbe JC, Holst CR, Bassett E, Tlsty T, Stampfer MR.

Cell Cycle. 2007 Aug 1;6(15):1927-36. Epub 2007 May 30.

PMID:
17671422
8.

ATF5 promotes cell survival through transcriptional activation of Hsp27 in H9c2 cells.

Wang H, Lin G, Zhang Z.

Cell Biol Int. 2007 Nov;31(11):1309-15. Epub 2007 May 21.

PMID:
17606386
10.

Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes.

Ma Q, Li X, Vale-Cruz D, Brown ML, Beier F, LuValle P.

J Cell Biochem. 2007 May 15;101(2):477-87.

PMID:
17219413
11.

ATF5 increases cisplatin-induced apoptosis through up-regulation of cyclin D3 transcription in HeLa cells.

Wei Y, Jiang J, Sun M, Chen X, Wang H, Gu J.

Biochem Biophys Res Commun. 2006 Jan 13;339(2):591-6. Epub 2005 Nov 17.

PMID:
16300731
12.

Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.

Angelastro JM, Canoll PD, Kuo J, Weicker M, Costa A, Bruce JN, Greene LA.

Oncogene. 2006 Feb 9;25(6):907-16.

PMID:
16170340
13.

ATF5 regulates the proliferation and differentiation of oligodendrocytes.

Mason JL, Angelastro JM, Ignatova TN, Kukekov VG, Lin G, Greene LA, Goldman JE.

Mol Cell Neurosci. 2005 Jul;29(3):372-80.

PMID:
15950153
14.

Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytes.

Angelastro JM, Mason JL, Ignatova TN, Kukekov VG, Stengren GB, Goldman JE, Greene LA.

J Neurosci. 2005 Apr 13;25(15):3889-99.

15.

Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.

Heckman CA, Wheeler MA, Boxer LM.

Oncogene. 2003 Sep 11;22(39):7891-9.

PMID:
12970736
16.

Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons.

Angelastro JM, Ignatova TN, Kukekov VG, Steindler DA, Stengren GB, Mendelsohn C, Greene LA.

J Neurosci. 2003 Jun 1;23(11):4590-600.

17.

The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2.

Decary S, Decesse JT, Ogryzko V, Reed JC, Naguibneva I, Harel-Bellan A, Cremisi CE.

Mol Cell Biol. 2002 Nov;22(22):7877-88.

18.
19.

NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.

Heckman CA, Mehew JW, Boxer LM.

Oncogene. 2002 May 30;21(24):3898-908.

20.

Supplemental Content

Support Center